We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Allurion Technologies Inc (ALUR) USD0.0001

Sell:$0.85 Buy:$0.85 Change: $0.0248 (2.82%)
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
Change: $0.0248 (2.82%)
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
Change: $0.0248 (2.82%)
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.

Contact details

11 Huron Dr Ste 200
United States
+1 (508) 6474000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$58.34 million
Shares in issue:
62.31 million
Specialized Consumer Services
United States
US dollar

Key personnel

  • Omar Syed Ishrak
    Lead Independent Co-Chairman of the Board
  • Krishna Gupta
    Independent Co-Chairman of the Board
  • Shantanu Gaur
    Chief Executive Officer, Director
  • Christopher Geberth
    Chief Financial Officer
  • Ojas Buch
    Chief Operating Officer
  • Ram Chuttani
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.